99 related articles for article (PubMed ID: 6277060)
1. The regulation of the human antitumor immune response to organ-specific neoantigens.
Thomson DM; Phelan K; Scanzano R; Fink A
Transplant Proc; 1981 Dec; 13(4):1952-4. PubMed ID: 6277060
[No Abstract] [Full Text] [Related]
2. Human tumor-specific immunity assayed by a computerized tube leukocyte adherence inhibition.
Thomson DM; Tataryn DN; Lopez M; Schwartz R; MacFarlane JK
Cancer Res; 1979 Feb; 39(2 Pt 2):638-43. PubMed ID: 83918
[No Abstract] [Full Text] [Related]
3. Expression of organ-specific neoantigens by human cancer.
Thomson DM
Prog Clin Biol Res; 1983; 132E():193-202. PubMed ID: 6196786
[No Abstract] [Full Text] [Related]
4. [Human antitumor immunity according to leukocyte adherence inhibition test data].
Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
[TBL] [Abstract][Full Text] [Related]
5. [Leukocyte adherence inhibition test in tumor patients].
Martínez Martínez B; Ordóñez Gallego A; Juárez Alonso S; González Barón M; Montero García JM
Rev Esp Oncol; 1982; 29(4):735-42. PubMed ID: 6927371
[TBL] [Abstract][Full Text] [Related]
6. [Immunologic diagnosis of malignant neoplasms. I].
Shuster J; Thomson DM; Fuks A; Gold P
Union Med Can; 1980 Jun; 109(6):902-9. PubMed ID: 7008310
[No Abstract] [Full Text] [Related]
7. Human cancers transplanted in nude mice retain the expression of their organ-specific neoantigens.
Thomson DM; Neville AM; Phelan K; Scanzano RS; Vandevoorde JP
Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1191-7. PubMed ID: 7199466
[No Abstract] [Full Text] [Related]
8. Experiences with leukocyte adherence inhibition in human cancer.
Maluish AE
Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
[No Abstract] [Full Text] [Related]
9. [Specific immunity in patients with carcinoma of the pancreas. Preliminary report].
Mester M; Zuliani A; Scheinberg MA; Machado MC
Rev Hosp Clin Fac Med Sao Paulo; 1983 Jun; 38(3):107-10. PubMed ID: 6364296
[No Abstract] [Full Text] [Related]
10. Summary and future prospects of leukocyte adherence inhibition.
Goldrosen MH
Cancer Res; 1979 Feb; 39(2 Pt 2):660-2. PubMed ID: 367591
[No Abstract] [Full Text] [Related]
11. [The leukocyte adherence inhibition test in diagnostics of malignancies (author's transl)].
Sarosiek J; Borejszo I
Przegl Lek; 1981; 38(7):561-5. PubMed ID: 7025111
[No Abstract] [Full Text] [Related]
12. Cell-mediated immunity in prostatic cancer.
Ablin RJ; Bhatti RA; Nagubadi S; Zamora S; Guinan PD
Clin Oncol; 1980 Sep; 6(3):253-64. PubMed ID: 7428203
[No Abstract] [Full Text] [Related]
13. [Modulating action of interferon preparations on cellular reactions of antitumor immunity].
Mkrtchian LN; Ter-Pogosian ZR; Sarkisian OM; Gevorkian RA; Movsesian EA
Vopr Onkol; 1983; 29(8):7-11. PubMed ID: 6351429
[TBL] [Abstract][Full Text] [Related]
14. Cellular immunity to tumor-associated antigens in man.
Hellström KE; Hellström I
N Engl J Med; 1977 Apr; 296(15):874-5. PubMed ID: 321957
[No Abstract] [Full Text] [Related]
15. The leukocyte adherence inhibition test in tumor patients using 3M KCl extracts of fetal tissues as antigens.
Albrecht S; Schlott B; Pasternak G; Reinhöfer J; Lunow G
Arch Geschwulstforsch; 1982; 52(5):341-8. PubMed ID: 7149907
[TBL] [Abstract][Full Text] [Related]
16. [Cellular antitumor immunity in an autologous system in stomach cancer].
Kurtenkov OA
Vopr Onkol; 1981; 27(6):36-40. PubMed ID: 7269415
[TBL] [Abstract][Full Text] [Related]
17. [Immunologic localization of primary tumors].
Muhrer KH; Filler D; Pasurka B
Chirurg; 1982 Apr; 53(4):258-62. PubMed ID: 7083967
[TBL] [Abstract][Full Text] [Related]
18. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
19. Tube LAI assay in diagnosis and monitoring of a cancer disease.
Hasek M; Holán V; Kousalová M
Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
[TBL] [Abstract][Full Text] [Related]
20. [Immune reaction to neoplasm antigens].
Oettgen HF
Verh Dtsch Ges Inn Med; 1972; 78():751-5. PubMed ID: 4353155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
